- Home
- RXRX vs NVG Comparison
RXRX vs NVG Comparison
Compare RXRX & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- NVG
- Stock Information
- Founded
- RXRX 2013
- NVG 1999
- Country
- RXRX United States
- NVG United States
- Employees
- RXRX N/A
- NVG N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- NVG Investment Managers
- Sector
- RXRX Health Care
- NVG Finance
- Exchange
- RXRX Nasdaq
- NVG Nasdaq
- Market Cap
- RXRX 2.1B
- NVG 2.6B
- IPO Year
- RXRX 2021
- NVG N/A
- Fundamental
- Price
- RXRX $5.91
- NVG $12.39
- Analyst Decision
- RXRX Buy
- NVG
- Analyst Count
- RXRX 4
- NVG 0
- Target Price
- RXRX $7.25
- NVG N/A
- AVG Volume (30 Days)
- RXRX 39.6M
- NVG 568.8K
- Earning Date
- RXRX 11-05-2025
- NVG 01-01-0001
- Dividend Yield
- RXRX N/A
- NVG 4.65%
- EPS Growth
- RXRX N/A
- NVG N/A
- EPS
- RXRX N/A
- NVG N/A
- Revenue
- RXRX $64,596,000.00
- NVG N/A
- Revenue This Year
- RXRX $24.17
- NVG N/A
- Revenue Next Year
- RXRX $20.98
- NVG N/A
- P/E Ratio
- RXRX N/A
- NVG N/A
- Revenue Growth
- RXRX 30.14
- NVG N/A
- 52 Week Low
- RXRX $3.79
- NVG $9.68
- 52 Week High
- RXRX $12.36
- NVG $12.21
- Technical
- Relative Strength Index (RSI)
- RXRX 62.64
- NVG 61.17
- Support Level
- RXRX $5.11
- NVG $12.15
- Resistance Level
- RXRX $6.30
- NVG $12.44
- Average True Range (ATR)
- RXRX 0.39
- NVG 0.09
- MACD
- RXRX 0.12
- NVG -0.01
- Stochastic Oscillator
- RXRX 70.23
- NVG 79.10
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.